Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders

Journal of Clinical Psychiatry

Volumn 75, Issue 7, 2014, Pages 720-727

  Leon, Andrew C ^a   Fiedorowicz, Jess G ^b   Solomon, David A ^c,d   Li, Chunshan ^a   Coryell, William H ^b   Endicott, Jean ^e   Fawcett, Jan ^f   Keller, Martin B ^c,g  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c BROWN UNIVERSITY   (United States)

^d UpToDate Inc   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^f UNIVERSITY OF NEW MEXICO   (United States)

^g BUTLER HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; ISOCARBOXAZID; LITHIUM; MAPROTILINE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SELEGILINE; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; VENLAFAXINE;

ADULT; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SCREENING; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROPENSITY SCORE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA; STATISTICAL MODEL; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; SURVIVAL; TEACHING HOSPITAL; UNITED STATES;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PROPENSITY SCORE; RISK; SUICIDE; SUICIDE, ATTEMPTED;

EID: 84905235135     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08744     Document Type: Article

References (48)

1. United States Food and Drug Administration. Briefing document for Psychopharmacologic Drugs Advisory Committee, December 13, 2006. Clinical review: relationship between antidepressant drugs and suicidality in adults. Page 28. www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf. Updated November 16, 2006. Accessed January 11, 2012.
2. United States Food and Drug Administration. Antidepressant use in children, adolescents, and young adults: revisions to product labeling. http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM173233. pdf. Updated 2007. Accessed January 11, 2012.
3. Leon AC, Solomon DA, Li C, et al. Antidepressants and risks of suicide and suicide attempts: a 27-year observational study. J Clin Psychiatry. 2011;72(5):580-586. doi:10.408/JCP.10m0652 PubMed
4. Goldberg JF. Antidepressant use and risk for suicide attempts in bipolar disorder. J Clin Psychiatry. 2011;72(12):1697, author reply 1697. doi:10.408/JCP.1lr07372 PubMed
5. Leon AC, Solomon DA, Li C, et al. Dr. Leon and colleagues reply. J Clin Psychiatry. 2011;72(12):1697-1698. doi:10.408/JCP.1lr07372a PubMed
6. Fiedorowicz JG, Leon AC, Keller MB, et al. Do risk factors for suicidal behavior differ by affective disorder polarity? Psychol Med. 2009;39(5):763-771. doi:10.1017/S0329170804078 PubMed
7. Katz MM, Klerman GL. Introduction: overview of the clinical studies program. Am J Psychiatry. 1979;136(1):49-51. PubMed
8. Solomon DA, Leon AC, Endicott J, et al. Empirical typology of bipolar I mood episodes. Br J Psychiatry. 2009;195(6):525-530. doi:10.192/bjp.bp.108. 062083 PubMed
9. Fiedorowicz JG, Solomon DA, Endicott J, et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med. 2009;71(6):598-606. doi:10.1097/PSY.0b013e3181ace26 PubMed
10. Coryell W, Fiedorowicz J, Leon AC, et al. Age of onset and the prospectively observed course of illness in bipolar disorder. J Affect Disord. 2013;146(1):34-38. PubMed
11. Solomon DA, Leon AC, Coryell WH, et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry. 2010;67(4):339-347. doi:10.101/archgenpsychiatry.2010.15 PubMed
12. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1978;35(7):837-844. doi:10.101/archpsyc.1978.01703104302 PubMed (Pubitemid 9076798)
13. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry. 1978;35(6):773-782. doi:10.101/archpsyc. 1978.01703015013 PubMed (Pubitemid 9064061)
14. Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44(6):540-548. doi:10.101/archpsyc.1987.0180180509 PubMed (Pubitemid 17082095)
15. Leon AC, Hedeker D. A mixed-effects quintile-stratified propensity adjustment for effectiveness analyses of ordered categorical doses. Stat Med. 2005;24(4):647-658. doi:10.102/sim.2042 PubMed (Pubitemid 40253613)
16. Leon AC, Hedeker D, Teres JJ. Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment. Stat Med. 2007;26(1):110-123. doi:10.102/sim.2458 PubMed (Pubitemid 46099420)
17. Rosenbaum P, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55. doi:10.1093/biomet/70.1.41
18. Leon AC, Solomon DA, Li C, et al. Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational study. Am J Psychiatry. 2012;169(3):285-291. doi:10.176/api.ajp.201.1060948 PubMed
19. Hedeker D, Gibbons RD, Du Toit SHC, et al. SuperMix - A Program for Mixed-Effects Regression Models. Chicago, IL: Scientific Software International; 2008.
20. Gu X, Rosenbaum PR. Comparison of multivariate matching methods: structures, distances, and algorithms. J Comput Graph Statist. 1993;2(4):405-420.
21. Hansen BB. Full matching in an observational study of coaching for the SAT. J Am Stat Assoc. 2004;99(467):609-618. doi:10.198/0162145040647 (Pubitemid 39332846)
22. Hansen BB, Klopfer SO. Optimal full matching and related designs via network flows. J Comput Graph Stat. 2005;15(3):609-627. doi:10.198/ 10618606x137047 (Pubitemid 44554199)
23. Kleyman Y, Hansen B. Basic uses of the OptMatch package. 2005. ftp://ftp.auckland.ac.nz/pub/software/CRAN/doc/vignettes/optmatch/optmatch.pdf. Udpated June 11, 2006. Accessed April 8, 2014.
24. Hansen BB, Fredrickson M. OptMatch package, version 0.7-1. http://cran.r-project.org/web/packages/optmatch/optmatch.pdf. Updated November 1, 2013. Accessed April 8, 2014.
25. Hedeker D, Siddiqui O, Hu FB. Random-effects regression analysis of correlated grouped-time survival data. Stat Methods Med Res. 2000;9(2):161-179. doi:10.191/09628067253473 PubMed (Pubitemid 30623558)
26. Endicott J, Cohen J, Nee J, et al. Hamilton Depression Rating Scale: extracted from Regular and Change Versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1981;38(1):98-103. doi:10.101/archpsyc.1981.01780260101 PubMed (Pubitemid 11156718)
27. Kraemer HC, Frank E. Evaluation of comparative treatment trials: assessing clinical benefits and risks for patients, rather than statistical effects on measures. JAMA. 2010;304(6):683-684. doi:10.101/jama.2010.13 PubMed
28. Frank E, Kupfer DJ, Rucci P, et al. Simultaneous evaluation of the harms and benefits of treatments in randomized clinical trials: demonstration of a new approach. Psychol Med. 2012;42(4):865-873. doi:10.1017/S032917101619 PubMed
29. Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013;170(11):1249-1262. doi:10.176/api.ajp. 2013.13020185 PubMed
30. Sachs GS, Koslow CL, Ghaemi SN. The treatment of bipolar depression. Bipolar Disord. 2000;2(3 pt 2):256-260. doi:10.1034/j.139-5618.20.20306.x PubMed
31. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry. 1987;144(11):1403-1411. PubMed (Pubitemid 18009530)
32. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161(9):1537-1547. doi:10.176/api.ajp.161.9.1537 PubMed (Pubitemid 39201448)
33. Post RM, Altshuler LL, Leverich GS, et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry. 2006;189(2):124-131. doi:10.192/bjp.bp.105.013045 PubMed (Pubitemid 44231270)
34. Vieta E, Martinez-Arán A, Goikolea JM, et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry. 2002;63(6):508-512. doi:10.408/JCP.v63n0607 PubMed (Pubitemid 34680359)
35. Altshuler LL, Suppes T, Black DO, et al. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry. 2006;163(2):313-315. doi:10.176/api.ajp.163.2.313 PubMed (Pubitemid 44480853)
36. Tondo L, Vázquez G, Baldessarini RJ. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand. 2010;121(6):404-414. doi:10.1/j.160-047.209.01514.x PubMed
37. United States Food and Drug Administration. Briefing document for Psychopharmacologic Drugs Advisory Committee, December 13, 2006: statistical evaluation of suicidality in adults treated with antidepressants. Pages 26-27. www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf. Updated November 16, 2006. Accessed March 28, 2013.
38. Gibbons RD, Brown CH, Hur K, et al. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Am J Psychiatry. 2007;164(7):1044-1049. doi:10.176/api.ajp.164.7.104 PubMed (Pubitemid 47121393)
39. Gibbons RD, Brown CH, Hur K, et al. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012;69(6):580-587. doi:10.101/archgenpsychiatry.201.2048 PubMed
40. Simon GE, Savarino J, Operskalski B, et al. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163(1):41-47. doi:10.176/api.ajp.163.1.41 PubMed
41. Simon GE, Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am J Psychiatry. 2007;164(7):1029-1034. doi:10.176/api.ajp.164.7.1029 PubMed (Pubitemid 47121391)
42. Yerevanian BI, Koek RJ, Mintz J, et al. Bipolar pharmacotherapy and suicidal behavior, part 2: the impact of antidepressants. J Affect Disord. 2007;103(1-3):13-21. doi:10.1016/j.jad.207.05.017 PubMed (Pubitemid 47445779)
43. Drake C. Effects of misspecification of the propensity score on estimators of the treatment effect. Biometrics. 1993;49(4):1231-1236. doi:10.2307/25326 (Pubitemid 24045302)
44. Leon AC, Hedeker D. Quantile stratification based on a misspecified propensity score in longitudinal treatment effectiveness analyses of ordinal doses. Comput Stat Data Anal. 2007;51(12):6114-6122. doi:10.1016/j.csda.206.12. 021 PubMed (Pubitemid 47126009)
45. Endicott J. Collaborative Depression Study procedures and study design. In: Keller MB, Coryell WH, Endicott J, et al, eds. Clinical Guide to Depression and Bipolar Disorder: Findings From the Collaborative Depression Study. Arlington, VA: American Psychiatric Publishing; 2013.
46. Klerman GL. Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology. Psychopharmacol Bull. 1986;22(1):25-29. PubMed (Pubitemid 16101328)
47. Peele PB, Xu Y, Kupfer DJ. Insurance expenditures on bipolar disorder: clinical and parity implications. Am J Psychiatry. 2003;160(7):1286-1290. doi:10.176/api.ajp.160.7.1286 PubMed (Pubitemid 41070945)
48. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356(17):1711-1722. doi:10.1056/NEJMoa064135 PubMed (Pubitemid 46658703)